GlassScriptPhysician profile
Elaine M Schmidt
NPI 1609853498
$1,228.34
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $653 · 2020: $156 · 2021: $28.60 · 2022: $46.00 · 2023: $306 · 2024: $38.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $357.16 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $193.80 | 2019-2023 | |
| Amgen INC. | $136.86 | 2019-2021 | |
| Edwards Lifesciences Corporation | $124.62 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novartis Pharmaceuticals Corporation | $120.37 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $39.08 | 2019-2023 | M-M-R II, Gardasil 9 |
| Astrazeneca Pharmaceuticals LP | $38.11 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $37.47 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.49 | 2019 | |
| Mylan Specialty L.P. | $28.22 | 2019 | |
| Ironshore Pharmaceuticals INC. | $20.94 | 2019 | |
| Halozyme INC | $19.60 | 2023 | |
| Daiichi Sankyo INC. | $19.19 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.33 | 2019 | |
| Radius Health, INC. | $14.82 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.63 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elaine Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.